en
E-mail us
(925) 558-5040
bd_global@crystalpharmatech.com
 cn
cn
Whitepaper Technical Insight Case Study Presentation
Showing 5 out of 5 results
Enabling Poorly Soluble Weak Bases for Improved Bioavailability: Why a Salt May Not be the Best Choice
Presentation
Enabling Poorly Soluble Weak Bases for Improved Bioavailability: Why a Salt May Not be the Best Choice

Speaker: Sheri Shamblin 

Company: Pfizer

01 Sep 2022
Solid Form Research |
Using Thermodynamic Phase Maps in API Crystallization Process Design
Presentation
Using Thermodynamic Phase Maps in API Crystallization Process Design

Speaker: Eric Sirota

Company: Merck

01 Sep 2022
Solid Form Research |
Effective Development of API Crystallization Processes During Drug Development
Presentation
Effective Development of API Crystallization Processes During Drug Development

Speaker: Jian Wang

Company: Crystal Pharmatech

01 Sep 2022
Solid Form Research |
Synthonic Engineering: Tools for the Rational Design of High Quality Pharmaceuticals
Presentation
Synthonic Engineering: Tools for the Rational Design of High Quality Pharmaceuticals

Speaker: Professor Kevin Roberts

Company: University of Leeds

01 Sep 2022
Solid Form Research |
Engineering Cocrystal Solubility and Streamlining Cocrystal Early Development
Presentation
Engineering Cocrystal Solubility and Streamlining Cocrystal Early Development

Speaker: Professor Nair Rodriguez

Company: University of Michigan

29 Aug 2022
Solid Form Research |
Small Molecule
Mol2Med™ Integrated Services Developability Assessment API Form and Solid-State Research Crystallization Development Services Pre-formulation Studies Formulation and Analytical Development GMP Manufacturing Clinical Supply
Crystal Bio Solutions
Biologics CMC Analytical Services Bioanalytical and Biomarker Services Quantitative Clinical Pharmacology (QCP)
Technology
Solid Form Screening Solid Form Developability Evaluation Absolute Structure Determination Crystallization Process Development Conventional Oral Solid Dosage Forms Bioavailability Enhancement for Insoluble Compounds & PROTAC & Oral Peptides Mini-tablet
Quick Links
Highlights News Events Knowledge Hub Webinar Series
Contact Us
bd_global@crystalpharmatech.com (925) 558-5040
U.S
NJ Sites: Suite 500-B, 3000 Eastpark Blvd, Cranbury, New Jersey, USA 08512
2005 Eastpark Blvd, Cranbury, New Jersey, USA 08512
CA Site: 7133 Koll Center Parkway, Suite 200, Pleasanton, California, USA 94566
Canada
6800 Kitimat Rd, Unit 1, Mississauga, Ontario, Canada L5N 5M1
China
No. 288, Jiangyun Road, Suzhou Industrial Park, Suzhou, China 215123

Subscribe to be the first to get the updates!

Subscribe to be the first to get the updates!
Privacy Policy
Sitemap
Small Molecule
Mol2Med™ Integrated Services Developability Assessment API Form and Solid-State Research Crystallization Development Services Pre-formulation Studies Formulation and Analytical Development GMP Manufacturing Clinical Supply
Crystal Bio Solutions
Biologics CMC Analytical Services Bioanalytical and Biomarker Services Quantitative Clinical Pharmacology (QCP)
Technology
Quick Links
About Us Events
NJ Sites: Suite 500-B, 3000 Eastpark Blvd, Cranbury, New Jersey, USA 08512
2005 Eastpark Blvd, Cranbury, New Jersey, USA 08512
CA Site: 7133 Koll Center Parkway, Suite 200, Pleasanton, California, USA 94566
bd_global@crystalpharmatech.com (925) 558-5040
Privacy Policy
Sitemap
We use cookies to offer you a better browsing experience, analyze site traffic and personalize content. Part of the tracking is necessary to ensure SEO effectiveness,
By using this site, you agree to our use of cookies. Visit our cookie policy to learn more.
Reject Accept